BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11751403)

  • 21. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
    Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
    Leong WF; Chau JF; Li B
    Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas.
    Polsky D; Young AZ; Busam KJ; Alani RM
    Cancer Res; 2001 Aug; 61(16):6008-11. PubMed ID: 11507043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
    Jones RA; Campbell CI; Petrik JJ; Moorehead RA
    Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro.
    Zhou HW; Lou SQ; Zhang K
    Rheumatology (Oxford); 2004 May; 43(5):555-68. PubMed ID: 15026580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.
    Xie Y; Skytting B; Nilsson G; Gasbarri A; Haslam K; Bartolazzi A; Brodin B; Mandahl N; Larsson O
    Cancer Res; 2002 Jul; 62(13):3861-7. PubMed ID: 12097301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.
    Matheu A; Pantoja C; Efeyan A; Criado LM; Martín-Caballero J; Flores JM; Klatt P; Serrano M
    Genes Dev; 2004 Nov; 18(22):2736-46. PubMed ID: 15520276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of simian virus 40 T-antigens on normal human mammary epithelial cells reveal evidence for spontaneous alterations in addition to loss of p16(INK4a) expression.
    Huschtscha LI; Neumann AA; Noble JR; Reddel RR
    Exp Cell Res; 2001 Apr; 265(1):125-34. PubMed ID: 11281650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis.
    Tort F; Bartkova J; Sehested M; Orntoft T; Lukas J; Bartek J
    Cancer Res; 2006 Nov; 66(21):10258-63. PubMed ID: 17079443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The p16(INK4A) protein and flavopiridol restore yeast cell growth inhibited by Cdk4.
    Moorthamer M; Panchal M; Greenhalf W; Chaudhuri B
    Biochem Biophys Res Commun; 1998 Sep; 250(3):791-7. PubMed ID: 9784425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced skin carcinogenesis in cyclin D1-conditional transgenic mice: cyclin D1 alters keratinocyte response to calcium-induced terminal differentiation.
    Yamamoto H; Ochiya T; Takeshita F; Toriyama-Baba H; Hirai K; Sasaki H; Sasaki H; Sakamoto H; Yoshida T; Saito I; Terada M
    Cancer Res; 2002 Mar; 62(6):1641-7. PubMed ID: 11912134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53.
    Klein A; Guhl E; Tzeng YJ; Fuhrhop J; Levrero M; Graessmann M; Graessmann A
    Oncogene; 2003 May; 22(19):2910-9. PubMed ID: 12771941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays.
    Tsiambas E; Karameris A; Gourgiotis S; Salemis N; Athanassiou AE; Karakitsos P; Papalois A; Merikas E; Kosmidis P; Patsouris E
    J BUON; 2007; 12(2):261-7. PubMed ID: 17600882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.
    Landis MW; Pawlyk BS; Li T; Sicinski P; Hinds PW
    Cancer Cell; 2006 Jan; 9(1):13-22. PubMed ID: 16413468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
    Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
    Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors.
    Ling H; Sylvestre JR; Jolicoeur P
    Oncogene; 2010 Aug; 29(32):4543-54. PubMed ID: 20562911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic stem cell ageing is uncoupled from p16 INK4A-mediated senescence.
    Attema JL; Pronk CJ; Norddahl GL; Nygren JM; Bryder D
    Oncogene; 2009 Jun; 28(22):2238-43. PubMed ID: 19398954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
    Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.